|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001420506-22-001068
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
Capital Impact Advisors, LLC
|
1602198
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
1005
|
29001
|
SH
|
|
SOLE
|
N/A
|
29001
|
0
|
0
|
May 17th, 2022 01:50AM
|
May 17th, 2022 01:50AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001420506-22-001008
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
ELEQUIN CAPITAL LP
|
1810873
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
2
|
59
|
SH
|
|
SOLE
|
|
59
|
0
|
0
|
May 17th, 2022 01:50AM
|
May 17th, 2022 01:50AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001420506-22-000986
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
Y-Intercept (Hong Kong) Ltd
|
1772875
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
286
|
8245
|
SH
|
|
SOLE
|
|
8245
|
0
|
0
|
May 17th, 2022 01:50AM
|
May 17th, 2022 01:50AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001315863-22-000386
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
DSC Advisors, L.P.
|
1299434
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
5542
|
160000
|
SH
|
|
SOLE
|
|
160000
|
0
|
0
|
May 17th, 2022 01:48AM
|
May 17th, 2022 01:48AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001315863-22-000379
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
Crestline Management, LP
|
1536054
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
1223
|
35295
|
SH
|
|
SOLE
|
|
35295
|
0
|
0
|
May 17th, 2022 01:48AM
|
May 17th, 2022 01:48AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001275218-22-000002
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
ALGERT GLOBAL LLC
|
1275218
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
887
|
25598
|
SH
|
|
SOLE
|
0
|
25598
|
0
|
0
|
May 17th, 2022 01:48AM
|
May 17th, 2022 01:48AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001214659-22-007031
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
VOLORIDGE INVESTMENT MANAGEMENT, LLC
|
1556921
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
2048
|
59113
|
SH
|
|
SOLE
|
|
59113
|
0
|
0
|
May 17th, 2022 01:48AM
|
May 17th, 2022 01:48AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001214659-22-007030
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
TWINBEECH CAPITAL LP
|
1769646
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
1951
|
56322
|
SH
|
|
SOLE
|
|
56322
|
0
|
0
|
May 17th, 2022 01:48AM
|
May 17th, 2022 01:48AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001172661-22-001468
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
Squarepoint Ops LLC
|
1642575
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
2618
|
75578
|
SH
|
|
DFND
|
1
|
0
|
75578
|
0
|
May 17th, 2022 01:47AM
|
May 17th, 2022 01:47AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:gbt
|
nasdaq:gbt Shareholders
|
13F-HR
|
0001172661-22-001456
|
Mar 31st, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
May 16th, 2022 12:00AM
|
ORBIMED ADVISORS LLC
|
1055951
|
GLOBAL BLOOD THERAPEUTICS IN
|
COM
|
37890U108
|
1732
|
50000
|
SH
|
Call
|
DFND
|
|
24000
|
0
|
26000
|
May 17th, 2022 01:47AM
|
May 17th, 2022 01:47AM
|
Global Blood Therapeutics
|
Health Care
|
Pharmaceuticals & Biotechnology
|